Nanalyze January 6, 2025

The mythical “cure for cancer” is often misunderstood. It’s not one wonder drug for the more than 200 types of cancer out there. Each person’s cancer is unique and accompanied by a distinct genetic fingerprint that can be targeted using personalized medicine. These often take the form of expensive cancer drugs, and investing in these drug developers means exposure to lots of external risk factors that can’t be controlled which create lots of volatility. As risk averse investors, we want to reduce volatility.

Perhaps the easiest cure for cancer is simply early detection. Take breast cancer, for instance. A study on early detection showed that “personal cure is achieved for the great majority” when cancer is detected in the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Provider
GenAI is already transforming the healthcare industry
Where Medicaid cuts stand
Q&A: Rural hospitals need help with cybersecurity survival
Radiology provider MedQuest part of deal to acquire 18 imaging centers from 1 of nation’s largest orthopedic groups
ASC block utilization by specialty

Share This Article